Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study Between YHP2407 and YHR2502 in Healthy Subjects
NCT06926387Phase 1Completed
- Sponsor
- Yuhan
- Start
- Apr 2025
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of YHP2407 (2 arms), sponsored by Yuhan. Primary endpoints: Area under the plasma drug concentration-time curve from time 0 to the last measurable concentration and Maximum plasma concentration. Started Apr 2025; status: completed.
02
Drugs
YHP2407
Beyond the preview
Go deeper on NCT06926387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06926387.